The previous studies showed that alternatively activated anti-inflammatory macrophage (M2) adoptive immunity can improve the proportion of local M2 cells and play the neuroprotective effect after spinal cord injury (SCI). Its molecular mechanism is not yet very clear. Therefore, this study aims to analyze the effect of the M2 adoptive transfer on the local expression of gene transcription. Sprague-Dawley (SD) rats were used for culture of macrophages and establishment of SCI models. After SCI, the polarized M2 macrophages were transferred to the injured rats by tail vein injection. Seven days after operation, the differentially expressed genes (DEGs) in the spinal cords were analyzed by RNA-sequencing (RNA-Seq). Then, the functional enrichment analysis and pathways were performed by using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), respectively. RNA-Seq showed that M2 adoptive immunity can down-regulate many well-studied gene expressions associated with signaling pathways of inflammatory, such as antigen processing and presentation, phagosome, cell adhesion molecules, natural killer cell-mediated cytotoxicity, endocytosis, proteasome, and Toll-like receptor signaling pathway. These may explain the mechanism of our previous adoptive immunization of M2 cells to provide neuroprotection for SCI. In addition, a novel pathway, retinoic acid-inducible gene-1 (RIG-I)-like receptor signaling pathway was found to be involved in the pathological process of SCI and the response to M2 adoptive immunity as well. This will provide a new explanation for the pathological mechanism of SCI and a new theoretical and experimental basis for its clinical treatment. The raw Illumina data are available at http://www.ncbi.nlm.nih.gov/sra (accession number PRJNA517238).
Impact statement
This research aimed to analyze the effect of M2 macrophage adoptive transfer on the local expression of gene transcription after SCI by RNA-Seq. The results showed that M2 adoptive immunity can down-regulate many well-studied gene expressions associated with signaling pathways of inflammatory. These may explain the mechanism of our previous adoptive immunization of M2 cells to provide neuroprotection for SCI. In addition, a novel pathway, RIG-I-like receptor signaling pathway was also found to involve in the pathological process of SCI and the response to M2 adoptive immunity. This will provide a new explanation for the pathological mechanism of SCI and a new theoretical and experimental basis for its clinical treatment.
FriedliLRosenzweigESBarraudQSchubertMDominiciNAwaiLNielsonJLMusienkoPNout-LomasYZhongHZdunowskiSRoyRRStrandSCvan den BrandRHavtonLABeattieMSBresnahanJCBezardEBlochJEdgertonVRFergusonARCurtATuszynskiMHCourtineG.Pronounced species divergence in corticospinal tract reorganization and functional recovery after lateralized spinal cord injury favors primates. Sci Transl Med2015;
7:302ra134
2.
DavidSKronerA.Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci2011;
12:388–99
3.
ShechterRMillerOYovelGRosenzweigNLondonARuckhJKimKWKleinEKalchenkoVBendelPLiraSAJungSSchwartzM.Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity2013;
38:555–69
4.
ChengHCaoYOlsonL.Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science1996;
273:510–3
5.
KuoHSTsaiMJHuangMCHuangWCLeeMJKuoWCYouLHSzetoKCTsaiILChangWCChiuCWMaHChakKFChengH.The combination of peripheral nerve grafts and acidic fibroblast growth factor enhances arginase I and polyamine spermine expression in transected rat spinal cords. Biochem Biophys Res Commun2007;
357:1–7
6.
KuoHSTsaiMJHuangMCChiuCWTsaiCYLeeMJHuangWCLinYLKuoWCChengH.Acid fibroblast growth factor and peripheral nerve grafts regulate Th2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords. J Neurosci2011;
31:4137–47
7.
BuschSAHornKPSilverDJSilverJ.Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci2009;
29:9967–76
8.
KigerlKAGenselJCAnkenyDPAlexanderJKDonnellyDJPopovichPG.Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci2009;
29:13435–44
9.
GordonS.Alternative activation of macrophages. Nat Rev Immunol2003;
3:23–35
10.
McWhorterFYWangTNguyenPChungTLiuWF.Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci U S A2013;
110:17253–8
11.
CassettaLCassolEPoliG.Macrophage polarization in health and disease. Sci World J2011;
11:2391–402
12.
ChenYJZhuHZhangNShenLWangRZhouJSHuJGLuHZ.Temporal kinetics of macrophage polarization in the injured rat spinal cord. J Neurosci Res2015;
93:1526–33
13.
MaSFChenYJZhangJXShenLWangRZhouJSHuJGLüHZ.Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury. Brain Behav Immun2015;
45:157–70
14.
DaviesJQGordonS.Isolation and culture of murine macrophages. Methods Mol Biol2005;
290:91–103
15.
NakagawaYWatariEShimizuMTakahashiH.One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry. Biomed Res2011;
32:159–66
16.
ShiLLZhangNXieXMChenYJWangRShenLZhouJSHuJGLuHZ.Transcriptome profile of rat genes in injured spinal cord at different stages by RNA-sequencing. BMC Genomics2017;
18:173
17.
LivakKJSchmittgenTD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods2001;
25:402–8
18.
FujimuraTKambayashiYFurudateSKakizakiAAibaS.Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase 1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma. Clin Dev Immunol2013;
2013:325412
19.
IshizukaEKFerreiraMJGrundLZCoutinhoEMKomegaeENCassadoAABortoluciKRLopes-FerreiraMLimaC.Role of interplay between IL-4 and IFN-gamma in the in regulating M1 macrophage polarization induced by Nattectin. Int Immunopharmacol2012;
14:513–22
20.
GrisPMurphySJacobJEAtkinsonIBrownA.Differential gene expression profiles in embryonic, adult-injured and adult-uninjured rat spinal cords. Mol Cell Neurosci2003;
24:555–67
21.
KotipatruniRRDasariVRVeeravalliKKDinhDHFassettDRaoJS.p53- and Bax-mediated apoptosis in injured rat spinal cord. Neurochem Res2011;
36:2063–74
22.
RuhlenRLSinghVKPazdernikVKTownsLCSniderEJSargentiniNJDegenhardtBF.Changes in rat spinal cord gene expression after inflammatory hyperalgesia of the joint and manual therapy. JAOA2014;
114:768–76
23.
HuangQWuLYWangYZhangXS.GOMA: functional enrichment analysis tool based on GO modules. Chin J Cancer2013;
32:195–204
24.
BloomO.Non-mammalian model systems for studying neuro-immune interactions after spinal cord injury. Exp Neurol2014;
258:130–40
25.
DavidSGreenhalghADKronerA.Macrophage and microglial plasticity in the injured spinal cord. Neuroscience2015;
307:311–8
26.
SchwabJMZhangYKoppMABrommerBPopovichPG.The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol2014;
258:121–9
27.
HeldKSLaneTE.Spinal cord injury, immunodepression, and antigenic challenge. Semin Immunol2014;
26:415–20
28.
KilanczykEAndresKRHallgrenJOhriSSLaihoMWhittemoreSRHetmanM.Pharmacological inhibition of spinal cord injury-stimulated ribosomal biogenesis does not affect locomotor outcome. Neurosci Lett2017;
642:153–7
29.
SlomnickiLPPietrzakMVashishtaAJonesJLynchNElliotSPoulosEMalicoteDMorrisBEHallgrenJHetmanM.Requirement of neuronal ribosome synthesis for growth and maintenance of the dendritic tree. J Biol Chem2016;
291:5721–39
30.
HetmanMSlomnickiLP.Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies. J Neurochem2019;
148:325–47
31.
CoyleDE.Spinal cord transcriptional profile analysis reveals protein trafficking and RNA processing as prominent processes regulated by tactile allodynia. Neuroscience2007;
144:144–56
32.
ZhouSDingFGuX.Non-coding RNAs as emerging regulators of neural injury responses and regeneration. Neurosci Bull2016;
32:253–64
33.
ChandranRMehtaSLVemugantiR.Non-coding RNAs and neuroprotection after acute CNS injuries. Neurochem Int2017;
111:12–22
34.
BhalalaOGSrikanthMKesslerJA.The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol2013;
9:328–39
35.
FuXShenYWangWLiX.MiR-30a-5p ameliorates spinal cord injury-induced inflammatory responses and oxidative stress by targeting Neurod 1 through MAPK/ERK signalling. Clin Exp Pharmacol Physiol2018;
45:68–74
36.
RuanWNingGFengSGaoSHaoY.MicroRNA381/Hes1 is a potential therapeutic target for spinal cord injury. Int J Mol Med2018;
42:1008–17
37.
ZhuHXieRLiuXShouJGuWGuSCheX.MicroRNA-494 improves functional recovery and inhibits apoptosis by modulating PTEN/AKT/mTOR pathway in rats after spinal cord injury. Biomed Pharmacother2017;
92:879–87
38.
JiangRZhangCGuRWuH.MicroRNA-489-3p inhibits neurite growth by regulating PI3K/AKT pathway in spinal cord injury. Pharmazie2017;
72:272–8
39.
GuSXieRLiuXShouJGuWCheX.Long coding RNA XIST contributes to neuronal apoptosis through the downregulation of AKT phosphorylation and is negatively regulated by miR-494 in rat spinal cord injury. IJMS2017;
18:pii: E732
40.
DuranRCYanHZhengYHuangXGrillRKimDHCaoQWuJQ.The systematic analysis of coding and long non-coding RNAs in the sub-chronic and chronic stages of spinal cord injury. Sci Rep2017;
7:41008
41.
KanehisaMGotoSFurumichiMTanabeMHirakawaM.KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res2010;
38:D355–60
42.
CruseJMLewisREBishopGRLamptonJAMalloryMDBryantMLKeithJC.Adhesion molecules and wound healing in spinal cord injury. Pathobiology1996;
64:193–7
43.
JakovcevskiIWuJKarlNLeshchyns'kaISytnykVChenJIrintchevASchachnerM.Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury. J Neurosci2007;
27:7222–33
44.
BaekAChoSRKimSH.Elucidation of gene expression patterns in the brain after spinal cord injury. Cell Transplant2017;
26:1286–300
45.
WenTHouJWangFZhangYZhangTSunT.Comparative analysis of molecular mechanism of spinal cord injury with time based on bioinformatics data. Spinal Cord2016;
54:431–8
46.
YangZLvQWangZDongXYangRZhaoW.Identification of crucial genes associated with rat traumatic spinal cord injury. Mol Med Rep2017;
15:1997–2006
47.
LaginhaIKoppMADruschelCSchaserKDBrommerBHellmannRCWatzlawickROssami-SaidiRRPrussHFailliVMeiselCLiebscherTPrilippENiedeggenAEkkernkampAGrittnerUPiperSKDirnaglUKilligMRomagnaniCSchwabJM.Natural killer (NK) cell functionality after human spinal cord injury (SCI): protocol of a prospective, longitudinal study. BMC Neurol2016;
16:170
48.
LiHZhangQYangXWangL.PPAR-gamma agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury. Neurosci Lett2017;
650:89–96
49.
ZhouKSansurCAXuHJiaX.The temporal pattern, flux, and function of autophagy in spinal cord injury. IJMS2017;
18:pii: E466
50.
GongBRadulovicMFigueiredo-PereiraMECardozoC.The ubiquitin-proteasome system: potential therapeutic targets for Alzheimer's disease and spinal cord injury. Front Mol Neurosci2016;
9:4
51.
SharmaHSMuresanuDFLafuenteJVSjoquistPOPatnaikRSharmaA.Nanoparticles exacerbate both ubiquitin and heat shock protein expressions in spinal cord injury: neuroprotective effects of the proteasome inhibitor carfilzomib and the antioxidant compound H-290/51. Mol Neurobiol2015;
52:882–98
52.
LiuJZhangSFanXYuanFDaiJHuJ.Dexmedetomidine preconditioning ameliorates inflammation and blood–spinal cord barrier damage after spinal cord ischemia-reperfusion injury by down-regulation high mobility group box 1-toll-like receptor 4-nuclear factor kappaB signaling pathway. Spine2019;
44:E74–E81
53.
ImpellizzeriDAhmadADi PaolaRCampoloMNavarraMEspositoECuzzocreaS.Role of toll like receptor 4 signaling pathway in the secondary damage induced by experimental spinal cord injury. Immunobiology2015;
220:1039–49
54.
YoneyamaMFujitaT.Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem2007;
282:15315–8
